Factors associated with serum HCV RNA positivity in anti-HCV antibody positive intravenous drug users

被引:11
作者
Pirisi, M [1 ]
Toniutto, P
Fabris, C
Lombardelli, T
Falleti, E
Tisminetzky, SG
Baralle, F
Bartoli, E
机构
[1] Univ Udine, Cattedra Med Interna, Dipartimento Patol & Med Sperimentale & Clin, I-33100 Udine, Italy
[2] Serv Tossicodipendenze, Udine, Italy
[3] Int Ctr Genet Engn & Biotechnol, I-34012 Trieste, Italy
关键词
hepatitis C virus; intravenous drug users; alcohol; life styles; liver disease; infection;
D O I
10.1016/S0895-4356(97)00305-3
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Serum hepatitis C virus (HCV) RNA, HCV genotypes and liver function tests were evaluated in a series of 189 unselected, consecutive anti-HCV positive intravenous drug users (IVDUs). Serum HCV RNA was detected in 106/189 patients. Abnormal liver function tests were associated with alcohol abuse, but not with the presence of serum HCV RNA. Among 109 patients retested after a mean follow-up of 21 months, 41 were intermittently serum HCV RNA positive. Patients persistently negative had more commonly a past history of acute hepatitis. A history of prostitution and/or a pattern of abuse involving >30 injections per week were related to infection by genotype 3a. In conclusion, serum HCV RNA is either transiently or persistently detectable in most anti-HCV positive IVDUs, but bears no association with abnormal liver biochemistry. Infection by HCV-3a is more common in IVDUs with more deviant life styles. In those cases where serum HCV RNA is found repeatedly negative, HCV infection may have been cleared, possibly through an episode of acute hepatitis. (C) 1998 Elsevier Science Inc.
引用
收藏
页码:423 / 427
页数:5
相关论文
共 25 条
[1]   EPIDEMIOLOGY OF HEPATITIS-C IN THE WEST [J].
ALTER, MJ .
SEMINARS IN LIVER DISEASE, 1995, 15 (01) :5-14
[2]   THE MEDICAL COMPLICATIONS OF DRUG-ADDICTION AND THE MEDICAL ASSESSMENT OF THE INTRAVENOUS-DRUG-USER - 25 YEARS LATER [J].
CHERUBIN, CE ;
SAPIRA, JD .
ANNALS OF INTERNAL MEDICINE, 1993, 119 (10) :1017-1028
[3]   ISOLATION OF A CDNA CLONE DERIVED FROM A BLOOD-BORNE NON-A, NON-B VIRAL-HEPATITIS GENOME [J].
CHOO, QL ;
KUO, G ;
WEINER, AJ ;
OVERBY, LR ;
BRADLEY, DW ;
HOUGHTON, M .
SCIENCE, 1989, 244 (4902) :359-362
[4]   CLINICAL-SIGNIFICANCE OF CONCOMITANT HEPATITIS-C INFECTION IN PATIENTS WITH ALCOHOLIC LIVER-DISEASE [J].
FONG, TL ;
KANEL, GC ;
CONRAD, A ;
VALINLUCK, B ;
CHARBONEAU, F ;
ADKINS, RH .
HEPATOLOGY, 1994, 19 (03) :554-557
[5]   LOWER SERUM HEPATITIS-C VIRUS-RNA TITERS IN PATIENTS WITH CONCURRENT CHRONIC HEPATITIS-B VIRUS-INFECTION [J].
FRANCOIS, M ;
ROINGEARD, P ;
DUBOIS, F ;
BACQ, Y ;
GOUDEAU, A ;
BARIN, F .
JOURNAL OF INFECTIOUS DISEASES, 1994, 169 (06) :1411-1412
[6]   THE PATHOLOGY OF HEPATITIS-C AS A FUNCTION OF MODE OF TRANSMISSION - BLOOD-TRANSFUSION VS INTRAVENOUS DRUG-USE [J].
GORDON, SC ;
ELLOWAY, RS ;
LONG, JC ;
DMUCHOWSKI, CF .
HEPATOLOGY, 1993, 18 (06) :1338-1343
[7]   ASSESSMENT OF HEPATITIS-C VIRUS-RNA LEVELS BY QUANTITATIVE COMPETITIVE RNA-POLYMERASE CHAIN-REACTION - HIGH-TITER VIREMIA CORRELATES WITH ADVANCED-STAGE OF DISEASE [J].
GRETCH, D ;
COREY, L ;
WILSON, J ;
DELAROSA, C ;
WILLSON, R ;
CARITHERS, R ;
BUSCH, M ;
HART, J ;
SAYERS, R ;
HAN, J .
JOURNAL OF INFECTIOUS DISEASES, 1994, 169 (06) :1219-1225
[8]   QUANTIFICATION OF HEPATITIS-C VIRUS BY COMPETITIVE REVERSE TRANSCRIPTION-POLYMERASE CHAIN-REACTION - INCREASE OF THE VIRUS IN ADVANCED LIVER-DISEASE [J].
KATO, N ;
YOKOSUKA, O ;
HOSODA, K ;
ITO, Y ;
OHTO, M ;
OMATA, M .
HEPATOLOGY, 1993, 18 (01) :16-20
[9]   NON-A, NON-B POSTTRANSFUSION HEPATITIS - LOOKING BACK IN THE 2ND DECADE [J].
KORETZ, RL ;
ABBEY, H ;
COLEMAN, E ;
GITNICK, G .
ANNALS OF INTERNAL MEDICINE, 1993, 119 (02) :110-115
[10]   SIGNIFICANCE OF SERUM HEPATITIS-C VIRUS-RNA LEVELS IN CHRONIC HEPATITIS-C [J].
LAU, JYN ;
DAVIS, GL ;
KNIFFEN, J ;
QIAN, KP ;
URDEA, MS ;
CHAN, CS ;
MIZOKAMI, M ;
NEUWALD, PD ;
WILBER, JC .
LANCET, 1993, 341 (8859) :1501-1504